Thomas Albert Nicolette - Net Worth and Insider Trading

Thomas Albert Nicolette Net Worth

The estimated net worth of Thomas Albert Nicolette is at least $494 dollars as of 2024-11-13. Thomas Albert Nicolette is the CEO and President of Akers Biosciences Inc and owns about 100 shares of Akers Biosciences Inc (AKER) stock worth over $494. Details can be seen in Thomas Albert Nicolette's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas Albert Nicolette has not made any transactions after 2014-01-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Thomas Albert Nicolette

Thomas Albert Nicolette Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas Albert Nicolette owns 4 companies in total, including VerifyMe Inc (VRME) , iNeedMD Holdings Inc (NEMD) , and Akers Biosciences Inc (AKER) among others .

Click here to see the complete history of Thomas Albert Nicolette’s form 4 insider trades.

Insider Ownership Summary of Thomas Albert Nicolette

Ticker	Comapny	Transaction Date	Type of Owner
VRME	VerifyMe Inc	2016-05-01	President & CEO
NEMD	iNeedMD Holdings Inc	2014-12-24	director & President and CEO
AKER	Akers Biosciences Inc	2014-01-23	director & CEO and President
		2014-01-23	director & CEO and President

Thomas Albert Nicolette Latest Holdings Summary

Thomas Albert Nicolette currently owns a total of 1 stock. Thomas Albert Nicolette owns 100 shares of Akers Biosciences Inc (AKER) as of January 23, 2014, with a value of $494.

Latest Holdings of Thomas Albert Nicolette

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
AKER	Akers Biosciences Inc	2014-01-23	100	4.94	494

Holding Weightings of Thomas Albert Nicolette

Thomas Albert Nicolette Form 4 Trading Tracker

According to the SEC Form 4 filings, Thomas Albert Nicolette has made a total of 0 transactions in Akers Biosciences Inc (AKER) over the past 5 years. The most-recent trade in Akers Biosciences Inc is the sale of 0 shares on January 23, 2014, which brought Thomas Albert Nicolette around $0.

Insider Trading History of Thomas Albert Nicolette

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Thomas Albert Nicolette Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Thomas Albert Nicolette Ownership Network

Ownership Network List of Thomas Albert Nicolette

No Data

Ownership Network Relation of Thomas Albert Nicolette

Thomas Albert Nicolette Owned Company Details

What does VerifyMe Inc do?

Who are the key executives at VerifyMe Inc?

Thomas Albert Nicolette is the President & CEO of VerifyMe Inc. Other key executives at VerifyMe Inc include EVP & Authentication Paul Joseph Ryan , VP-Ops & PeriShip Global LLC Fred Iii Volk , and CIO & PeriShip Global LLC Jack Wang .

VerifyMe Inc (VRME) Insider Trades Summary

Over the past 18 months, Thomas Albert Nicolette made no insider transaction in VerifyMe Inc (VRME). Other recent insider transactions involving VerifyMe Inc (VRME) include a net purchase of 84,908 shares made by Adam H Stedham , a net purchase of 18,234 shares made by Marshall S Geller , and a net purchase of 3,701 shares made by Scott N Greenberg .

In summary, during the past 3 months, insiders sold 0 shares of VerifyMe Inc (VRME) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VerifyMe Inc (VRME) were sold and 117,938 shares were bought by its insiders, resulting in a net purchase of 117,938 shares.

VerifyMe Inc (VRME)'s detailed insider trading history can be found in Insider Trading Tracker table.

VerifyMe Inc Insider Transactions

No Available Data

What does iNeedMD Holdings Inc do?

Who are the key executives at iNeedMD Holdings Inc?

Thomas Albert Nicolette is the director & President and CEO of iNeedMD Holdings Inc.

iNeedMD Holdings Inc (NEMD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of iNeedMD Holdings Inc (NEMD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of iNeedMD Holdings Inc (NEMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

iNeedMD Holdings Inc (NEMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

iNeedMD Holdings Inc Insider Transactions

No Available Data

What does Akers Biosciences Inc do?

Who are the key executives at Akers Biosciences Inc?

Thomas Albert Nicolette is the director & CEO and President of Akers Biosciences Inc. Other key executives at Akers Biosciences Inc include director & Exec. Chairman and President Christopher C Schreiber , Chief Financial Officer Stuart M Benson , and 10 percent owner Hudson Bay Capital Management Lp .

Akers Biosciences Inc (AKER) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Akers Biosciences Inc (AKER) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akers Biosciences Inc (AKER) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Akers Biosciences Inc (AKER)'s detailed insider trading history can be found in Insider Trading Tracker table.

Akers Biosciences Inc Insider Transactions

No Available Data

What does TNF Pharmaceuticals Inc do?

Who are the key executives at TNF Pharmaceuticals Inc?

Thomas Albert Nicolette is the director & CEO and President of TNF Pharmaceuticals Inc. Other key executives at TNF Pharmaceuticals Inc include EVP of Operations & GC Paul Rivard , director & President & Chief Med. Officer Chapman Christopher C Jr , and Chief Scientific Officer Adam Kaplin .

TNF Pharmaceuticals Inc (TNFA) Insider Trades Summary

Over the past 18 months, Thomas Albert Nicolette made no insider transaction in TNF Pharmaceuticals Inc (TNFA). Other recent insider transactions involving TNF Pharmaceuticals Inc (TNFA) include a net purchase of 175,000 shares made by Paul Rivard ,

In summary, during the past 3 months, insiders sold 0 shares of TNF Pharmaceuticals Inc (TNFA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TNF Pharmaceuticals Inc (TNFA) were sold and 5,833 shares were bought by its insiders, resulting in a net purchase of 5,833 shares.

TNF Pharmaceuticals Inc (TNFA)'s detailed insider trading history can be found in Insider Trading Tracker table.

TNF Pharmaceuticals Inc Insider Transactions

No Available Data

Thomas Albert Nicolette Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas Albert Nicolette. You might contact Thomas Albert Nicolette via mailing address: 7 Spring Hollow Road, Centerport Ny 11721.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.